These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 21624413

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Improvement of influenza vaccine strain A/Vietnam/1194/2004 (H5N1) growth with the neuraminidase packaging sequence from A/Puerto Rico/8/34.
    Pan W, Dong Z, Meng W, Zhang W, Li T, Li C, Zhang B, Chen L.
    Hum Vaccin Immunother; 2012 Feb; 8(2):252-9. PubMed ID: 22426370
    [Abstract] [Full Text] [Related]

  • 4. The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolate.
    Horimoto T, Takada A, Fujii K, Goto H, Hatta M, Watanabe S, Iwatsuki-Horimoto K, Ito M, Tagawa-Sakai Y, Yamada S, Ito H, Ito T, Imai M, Itamura S, Odagiri T, Tashiro M, Lim W, Guan Y, Peiris M, Kawaoka Y.
    Vaccine; 2006 Apr 24; 24(17):3669-76. PubMed ID: 16378663
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of gene constellation and postreassortment amino acid change on the phenotypic features of H5 influenza virus reassortants.
    Rudneva IA, Timofeeva TA, Shilov AA, Kochergin-Nikitsky KS, Varich NL, Ilyushina NA, Gambaryan AS, Krylov PS, Kaverin NV.
    Arch Virol; 2007 Apr 24; 152(6):1139-45. PubMed ID: 17294090
    [Abstract] [Full Text] [Related]

  • 7. Improved haemagglutinin antigen content in H5N1 candidate vaccine viruses with chimeric haemagglutinin molecules.
    Harvey R, Nicolson C, Johnson RE, Guilfoyle KA, Major DL, Robertson JS, Engelhardt OG.
    Vaccine; 2010 Nov 23; 28(50):8008-14. PubMed ID: 20934460
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Development of a new candidate H5N1 avian influenza virus for pre-pandemic vaccine production.
    Dong J, Matsuoka Y, Maines TR, Swayne DE, O'Neill E, Davis CT, Van-Hoven N, Balish A, Yu HJ, Katz JM, Klimov A, Cox N, Li DX, Wang Y, Guo YJ, Yang WZ, Donis RO, Shu YL.
    Influenza Other Respir Viruses; 2009 Nov 23; 3(6):287-95. PubMed ID: 19903211
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. H5N1 influenza marker vaccine for serological differentiation between vaccinated and infected chickens.
    Li C, Ping J, Jing B, Deng G, Jiang Y, Li Y, Tian G, Yu K, Bu Z, Chen H.
    Biochem Biophys Res Commun; 2008 Jul 25; 372(2):293-7. PubMed ID: 18501701
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses.
    Mahmood K, Bright RA, Mytle N, Carter DM, Crevar CJ, Achenbach JE, Heaton PM, Tumpey TM, Ross TM.
    Vaccine; 2008 Oct 03; 26(42):5393-9. PubMed ID: 18706956
    [Abstract] [Full Text] [Related]

  • 17. Reassortment and modification of hemagglutinin cleavage motif of avian/WSN influenza viruses generated by reverse genetics that correlate with attenuation.
    Lu JH, Long JX, Jia LJ, Liu YL, Shao WX, Zhang YM, Liu XF.
    Acta Virol; 2006 Oct 03; 50(4):243-9. PubMed ID: 17177609
    [Abstract] [Full Text] [Related]

  • 18. Preparation of genetically engineered A/H5N1 and A/H7N1 pandemic vaccine viruses by reverse genetics in a mixture of Vero and chicken embryo cells.
    Legastelois I, Garcia-Sastre A, Palese P, Tumpey TM, Maines TR, Katz JM, Vogel FR, Moste C.
    Influenza Other Respir Viruses; 2007 May 03; 1(3):95-104. PubMed ID: 19453414
    [Abstract] [Full Text] [Related]

  • 19. Development of Clade-Specific and Broadly Reactive Live Attenuated Influenza Virus Vaccines against Rapidly Evolving H5 Subtype Viruses.
    Boonnak K, Matsuoka Y, Wang W, Suguitan AL, Chen Z, Paskel M, Baz M, Moore I, Jin H, Subbarao K.
    J Virol; 2017 Aug 01; 91(15):. PubMed ID: 28490598
    [Abstract] [Full Text] [Related]

  • 20. Characterization of reverse genetics-derived cold-adapted master donor virus A/Leningrad/134/17/57 (H2N2) and reassortants with H5N1 surface genes in a mouse model.
    Isakova-Sivak I, Chen LM, Bourgeois M, Matsuoka Y, Voeten JT, Heldens JG, van den Bosch H, Klimov A, Rudenko L, Cox NJ, Donis RO.
    Clin Vaccine Immunol; 2014 May 01; 21(5):722-31. PubMed ID: 24648485
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.